Experimental Drug Retatrutide Shows Potential in Reducing Sleep Apnea Symptoms | Retatrutide News

Retatrutide, an experimental weight-loss drug, may improve sleep apnea symptoms. This suggests a broader therapeutic application for GLP-1 agonists.
Weight Loss · October 31, 2026